You are using an older browser version. Please use a supported version for the best MSN experience.

Oxford Covid vaccine shows strong immune response in older adults

Covid-19 vaccine being developed by British-Swedish pharmaceutical firm AstraZeneca and Oxford University produced a strong immune response in older adults, raising hopes that it can protect the age groups most at risk from the virus.

UP NEXT

UP NEXT

More From The Economic Times

More From The Economic Times

image beaconimage beaconimage beacon